_version_ 1783543807631949824
author Salinas-Vera, Yarely M.
Gallardo-Rincón, Dolores
García-Vázquez, Raúl
Hernández-de la Cruz, Olga N.
Marchat, Laurence A.
González-Barrios, Juan Antonio
Ruíz-García, Erika
Vázquez-Calzada, Carlos
Contreras-Sanzón, Estefanía
Resendiz-Hernández, Martha
Astudillo-de la Vega, Horacio
Cruz-Colin, José L.
Campos-Parra, Alma D.
López-Camarillo, César
author_facet Salinas-Vera, Yarely M.
Gallardo-Rincón, Dolores
García-Vázquez, Raúl
Hernández-de la Cruz, Olga N.
Marchat, Laurence A.
González-Barrios, Juan Antonio
Ruíz-García, Erika
Vázquez-Calzada, Carlos
Contreras-Sanzón, Estefanía
Resendiz-Hernández, Martha
Astudillo-de la Vega, Horacio
Cruz-Colin, José L.
Campos-Parra, Alma D.
López-Camarillo, César
author_sort Salinas-Vera, Yarely M.
collection PubMed
description
format Online
Article
Text
id pubmed-7280899
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72808992020-06-23 Corrigendum: HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells Salinas-Vera, Yarely M. Gallardo-Rincón, Dolores García-Vázquez, Raúl Hernández-de la Cruz, Olga N. Marchat, Laurence A. González-Barrios, Juan Antonio Ruíz-García, Erika Vázquez-Calzada, Carlos Contreras-Sanzón, Estefanía Resendiz-Hernández, Martha Astudillo-de la Vega, Horacio Cruz-Colin, José L. Campos-Parra, Alma D. López-Camarillo, César Front Oncol Oncology Frontiers Media S.A. 2020-06-02 /pmc/articles/PMC7280899/ /pubmed/32582552 http://dx.doi.org/10.3389/fonc.2020.00889 Text en Copyright © 2020 Salinas-Vera, Gallardo-Rincón, García-Vázquez, Hernández-de la Cruz, Marchat, González-Barrios, Ruíz-García, Vázquez-Calzada, Contreras-Sanzón, Resendiz-Hernández, Astudillo-de la Vega, Cruz-Colin, Campos-Parra and López-Camarillo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Salinas-Vera, Yarely M.
Gallardo-Rincón, Dolores
García-Vázquez, Raúl
Hernández-de la Cruz, Olga N.
Marchat, Laurence A.
González-Barrios, Juan Antonio
Ruíz-García, Erika
Vázquez-Calzada, Carlos
Contreras-Sanzón, Estefanía
Resendiz-Hernández, Martha
Astudillo-de la Vega, Horacio
Cruz-Colin, José L.
Campos-Parra, Alma D.
López-Camarillo, César
Corrigendum: HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells
title Corrigendum: HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells
title_full Corrigendum: HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells
title_fullStr Corrigendum: HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells
title_full_unstemmed Corrigendum: HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells
title_short Corrigendum: HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells
title_sort corrigendum: hypoxamirs profiling identify mir-765 as a regulator of the early stages of vasculogenic mimicry in skov3 ovarian cancer cells
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280899/
https://www.ncbi.nlm.nih.gov/pubmed/32582552
http://dx.doi.org/10.3389/fonc.2020.00889
work_keys_str_mv AT salinasverayarelym corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells
AT gallardorincondolores corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells
AT garciavazquezraul corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells
AT hernandezdelacruzolgan corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells
AT marchatlaurencea corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells
AT gonzalezbarriosjuanantonio corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells
AT ruizgarciaerika corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells
AT vazquezcalzadacarlos corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells
AT contrerassanzonestefania corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells
AT resendizhernandezmartha corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells
AT astudillodelavegahoracio corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells
AT cruzcolinjosel corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells
AT camposparraalmad corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells
AT lopezcamarillocesar corrigendumhypoxamirsprofilingidentifymir765asaregulatoroftheearlystagesofvasculogenicmimicryinskov3ovariancancercells